# Recursion Pharmaceuticals, Inc. (RXRX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $75M |
| 2024 | $59M |
| 2023 | $45M |
| 2022 | $40M |
| 2021 | $10M |
| 2020 | $4M |
| 2019 | $2M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $6M |
| 2025-09-30 | $5M |
| 2025-06-30 | $19M |
| 2025-03-31 | $15M |
| 2024-09-30 | $26M |
| 2024-06-30 | $14M |
| 2024-03-31 | $14M |
| 2023-09-30 | $11M |
| 2023-06-30 | $11M |
| 2023-03-31 | $12M |
| 2022-09-30 | $13M |
| 2022-06-30 | $8M |
| 2022-03-31 | $5M |
| 2021-09-30 | $3M |
| 2021-06-30 | $3M |
| 2021-03-31 | $3M |
| 2020-09-30 | $1M |
| 2020-06-30 | $186,000 |
| 2020-03-31 | $60,000 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/RXRX/revenue)